Globus Medical (GMED) Gains from Investment Securities (2016 - 2026)

Globus Medical's Gains from Investment Securities history runs 11 years deep, the most recent figure standing at $6.4 million for Q1 2026.

• Quarterly Gains from Investment Securities rose 3703.59% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (down 26.83% YoY) and the FY2025 annual result came in at $13.5 million, down 49.24% from the prior year.
• Gains from Investment Securities was $6.4 million for Q1 2026 at Globus Medical, down from $10.8 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $17.9 million in Q4 2024 and bottomed at -$4.1 million in Q3 2024.
• A 5-year average of $4.1 million and a median of $1.2 million in 2023 frame the typical range for Gains from Investment Securities.
• Annual changes were most pronounced in 2024 — Gains from Investment Securities plunged 458.91% — and 2026, when it soared 3703.59%.
• Globus Medical's Gains from Investment Securities stood at $7.2 million in 2022, then surged by 81.23% to $13.0 million in 2023, then surged by 37.76% to $17.9 million in 2024, then tumbled by 39.74% to $10.8 million in 2025, then tumbled by 41.15% to $6.4 million in 2026.
• Business Quant data shows GMED's Gains from Investment Securities at $6.4 million in Q1 2026, $10.8 million in Q4 2025, and -$2.7 million in Q3 2025.